About Index Trending news
Lists
Pricing
Avaxia Biologics

Avaxia Biologics

Avaxia Biologics

Avaxia Biologics develops orally-delivered antibody therapeutics using a proprietary antibody platform.

Elsewhere

Alexa global traffic share

Latest funding Show all
Convertible Note
Debt financing
$3,096,371
Employees

Unknown size

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Avaxia Biologics makes some noise.